Active Ingredient(s): Cerliponase Alfa
FDA Approved: * April 27, 2017
Pharm Company: * BIOMARIN PHARM
Category: Neurological Disorders
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Recent Brineura Forums:
Be the first to start a discussion
about this drug.
Possible Dosages for this and Related Drugs:
Note: Above list includes dosages for all drugs with the same combination of active ingredients.
NDC Database Records for Brineura: (1 result)
Sorted by National Drug Code
- 68135-811 Brineura Intraventricular Kit by Biomarin Pharmaceutical Inc.
Other drugs which contain Cerliponase Alfa or a similar ingredient: (1 result)